Chemical constituents of the root bark of Ulmus davidiana var. japonica and their potential biological activities.
Animals
Anti-Bacterial Agents
/ pharmacology
Anti-Inflammatory Agents
/ pharmacology
Cells, Cultured
Glioma
/ drug therapy
Helicobacter Infections
/ drug therapy
Helicobacter pylori
/ drug effects
Inflammation
/ drug therapy
Mice
Microglia
/ drug effects
Nerve Growth Factor
/ metabolism
Neuroprotective Agents
/ pharmacology
Nitric Oxide
/ metabolism
Plant Bark
/ chemistry
Plant Extracts
/ pharmacology
Plant Roots
/ chemistry
Rats
Ulmus
/ chemistry
Anti-Helicobacter pylori activity
Anti-neuroinflammation
Nerve growth factor (NGF)
Ulmaceae
Ulmus davidiana var. japonica
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
10 2019
10 2019
Historique:
received:
27
04
2019
revised:
02
07
2019
accepted:
20
07
2019
pubmed:
30
7
2019
medline:
21
10
2020
entrez:
30
7
2019
Statut:
ppublish
Résumé
The root bark of Ulmus davidiana var. japonica (Ulmaceae), commonly known as yugeunpi, has been used as a traditional Korean medicine for the treatment of gastroenteric and inflammatory disorders. As part of continuing projects to discover bioactive natural products from traditional medicinal plants with pharmacological potential, phytochemical investigation of the root bark of this plant was carried out. This led to the successful isolation of a new chromane derivative (1) and 22 known compounds: catechin derivatives (2-5), megastigmane glycoside (6), dihydrochalcone glycosides (7 and 8), flavanone glycosides (9 and 10), coumarins (11 and 12), lignan derivatives (13-17), and phenolic compounds (18-23). The structure of the new compound (1) was determined with 1D and 2D NMR spectroscopy and HR-ESIMS, and its absolute configurations were achieved by chemical reactions and the gauge-including atomic orbital (GIAO) NMR chemical shifts calculations. All the isolated compounds were evaluated for their potential biological activities including neuro-protective, anti-neuroinflammatory, and anti-Helicobacter pylori activities. Among the isolates, compounds 1, 8, and 20 displayed stronger potency by causing a greater increase in the production and the activity of nerve growth factor (NGF) in C6 glioma cells (147.04 ± 4.87, 206.27 ± 6.70, and 143.70 ± 0.88%, respectively), whereas compounds 11, 14, and 19 inhibited nitric oxide (NO) production in lipopolysaccharide (LPS)-stimulated murine microglial cells (IC
Identifiants
pubmed: 31357073
pii: S0045-2068(19)30664-9
doi: 10.1016/j.bioorg.2019.103145
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Inflammatory Agents
0
Neuroprotective Agents
0
Plant Extracts
0
Nitric Oxide
31C4KY9ESH
Nerve Growth Factor
9061-61-4
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103145Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.